Microbot Medical Inc (MBOT) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.049x

Based on the latest financial reports, Microbot Medical Inc (MBOT) has a cash flow conversion efficiency ratio of -0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.84 Million) by net assets ($78.22 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Microbot Medical Inc - Cash Flow Conversion Efficiency Trend (1991–2024)

This chart illustrates how Microbot Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Microbot Medical Inc debt and liabilities for a breakdown of total debt and financial obligations.

Microbot Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Microbot Medical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Yatas Yatak ve Yorgan Sanayi Ticaret AS
IS:YATAS
0.116x
First Guaranty Bancshares Inc
NASDAQ:FGBI
-0.843x
Zapata Computing Holdings Inc. Common Stock
NASDAQ:ZPTA
0.032x
MNtech Co. Ltd
KQ:095500
0.089x
Espey Mfg & Electronics Corp
NYSE MKT:ESP
0.112x
BANK OF JIUJIANG H YC1
F:BJ8
N/A
Sunko Ink Co Ltd
TW:1721
0.009x
Count Ltd
AU:CUP
0.106x

Annual Cash Flow Conversion Efficiency for Microbot Medical Inc (1991–2024)

The table below shows the annual cash flow conversion efficiency of Microbot Medical Inc from 1991 to 2024. For the full company profile with market capitalisation and key ratios, see MBOT company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $3.53 Million $-8.83 Million -2.501x -31.90%
2023-12-31 $4.50 Million $-8.53 Million -1.896x -19.65%
2022-12-31 $7.29 Million $-11.55 Million -1.584x -143.59%
2021-12-31 $14.38 Million $-9.35 Million -0.650x -118.02%
2020-12-31 $24.31 Million $-7.25 Million -0.298x -45.86%
2019-12-31 $31.54 Million $-6.45 Million -0.205x +94.88%
2018-12-31 $1.33 Million $-5.31 Million -3.992x -719.22%
2017-12-31 $9.96 Million $-4.86 Million -0.487x -5.16%
2016-12-31 $1.70 Million $-786.00K -0.463x -120.23%
2015-12-31 $-334.00K $-765.00K 2.290x +149.16%
2014-12-31 $5.87 Million $-27.35 Million -4.659x -198.73%
2013-12-31 $14.95 Million $-23.32 Million -1.560x -9.77%
2012-12-31 $13.98 Million $-19.87 Million -1.421x +30.92%
2011-12-31 $10.73 Million $-22.06 Million -2.057x -29.85%
2010-12-31 $15.48 Million $-24.52 Million -1.584x -95.69%
2009-12-31 $30.50 Million $-24.68 Million -0.809x +22.38%
2008-12-31 $21.81 Million $-22.74 Million -1.043x -76.04%
2007-12-31 $35.21 Million $-20.86 Million -0.592x -100.00%
2006-12-31 $54.38 Million $-16.10 Million -0.296x +19.23%
2005-12-31 $32.38 Million $-11.87 Million -0.367x -20.17%
2004-12-31 $36.95 Million $-11.27 Million -0.305x +60.84%
2003-12-31 $10.96 Million $-8.54 Million -0.779x +70.74%
2002-12-31 $3.79 Million $-10.09 Million -2.663x -234.50%
2001-12-31 $13.21 Million $-10.52 Million -0.796x -189.61%
2000-12-31 $22.98 Million $-6.32 Million -0.275x +92.28%
1999-12-31 $3.51 Million $-12.49 Million -3.562x -593.02%
1998-12-31 $17.90 Million $-9.20 Million -0.514x -7.64%
1997-12-31 $28.90 Million $-13.80 Million -0.478x -65.70%
1996-12-31 $34.70 Million $-10.00 Million -0.288x -227.09%
1995-12-31 $45.40 Million $-4.00 Million -0.088x +85.14%
1994-12-31 $22.60 Million $-13.40 Million -0.593x -71.90%
1993-12-31 $34.50 Million $-11.90 Million -0.345x -13.17%
1992-12-31 $29.20 Million $-8.90 Million -0.305x +10.95%
1991-12-31 $14.90 Million $-5.10 Million -0.342x --

About Microbot Medical Inc

NASDAQ:MBOT USA Medical Instruments & Supplies
Market Cap
$141.03 Million
Market Cap Rank
#17864 Global
#3989 in USA
Share Price
$2.10
Change (1 day)
+0.48%
52-Week Range
$1.62 - $4.50
All Time High
$891.00
About

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination f… Read more